It is labeled as "MLCL/CL ratio", defined as: "A diagnostic measurement of the ratio of monolysocardiolipin (MLCL) to cardiolipin (CL) in blood spots, used as a functional assay to identify Barth syndrome by assessing mitochondrial phospholipid remodeling.", also known as "monolysocardiolipin to cardiolipin ratio", and related terms include "mitochondrial phospholipid remodeling".